PPMA strongly refutes allegations against quality of Pakistani medicines
Pharmaceutical body defends industry standards, warns against harmful impact on exports and national reputation
Citi Pharma’s veterinary subsidiary begins operations, launching 32 products initially
Citi Veterinary Limited projects a turnover of Rs 1.5 billion for FY 2025-26, with plans to establish Pakistan's first dedicated veterinary Active Pharmaceutical Ingredient (API) plant
IPO proceeds in 2018 plunged by 49% to Rs4.8 billion
AGP Pharmaceutical, one of the largest companies in the country’s pharmaceutical sector via its offer for sale (OFS) collected 65% of total raised capital during 2018
GSK set to capitalise as Reckitt Benckiser pulls out of Pfizer deal
NEW YORK: British consumer goods group Reckitt Benckiser has pulled out of discussions with Pfizer over buying its consumer healthcare business, strengthening the hand of...
Searle secures DRAP’s approval for Denosumab biosimilar injections
Company prepares commercial rollout of 60mg and 120mg doses for osteoporosis and oncology care
CCP approves acquisition of two Japanese pharma products by Hilton Pharma
Proposed transaction entails the acquisition of Methycobal and Myonal including their trademarks
Searle Company to divest entire stake in Searle Pakistan Limited
Board approves disposal of 100% shareholding; negotiations for terms underway
Pakistan’s pharma sector eyes US market expansion with new tariff advantage
New tariff policy provides Pakistan a competitive edge over India and China; regulatory approvals from US authorities will be crucial for unlocking this potential
Haleon Pakistan targets expansion to 19 countries, aims for 10% export sales share
Haleon plans to boost exports and local manufacturing, with focus on Vietnam, Philippines and local sourcing to reduce import reliance
Britain nears 500 million pound deal for Sanofi, GSK Covid-19 vaccine
LONDON: Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline (GSK) for 60 million doses of...
Can Hamdard thrive in the era of the millennial consumer?
It is an ad that relies on contrasts: a product as traditionally Pakistani as Hamdard’s Rooh Afza being consumed by non-Pakistanis in New York’s...
Highnoon Laboratories partners with Bangladesh-based Beximco Pharmaceuticals for strategic collaboration
Both firms sign MoU to distribute and market specialised pharmaceutical products in Pakistan, focusing on key therapeutic areas
Lucky Core Industries expands portfolio with Pfizer assets acquisition
Deal includes a manufacturing facility, certain pharma products and trademarks associated with said products
Hoechst Pakistan to acquire products and trademarks from Sanofi affiliates
Board approves strategic acquisition to strengthen product portfolio and market position
Ferozsons subsidiary launches human insulin
Company says Ferulin, developed with the highest quality standards, will provide effective and affordable diabetes treatment to patients
